The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q).

NCT01556477 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

72

Enrollment

NETWORK

Sponsor class

Conditions

Myelodysplastic Syndrome
Acute Myelogenous Leukemia

Interventions

DRUG: Azacitidine
DRUG: azacitidine + lenalidomide

Sponsor

Nordic MDS Group